Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Cambridge

£23,678

2015

Epigenetic reprogramming underlies cell fate changes in development and regeneration. However appropriate tools to study these changes are currently lacking. We have developed a strategy to change local chromatin structure in a specific manner based on the Crispr/Cas9 system. Specifically, we generated a fusion protein of the enzymatic domain of the H3K9me2 methyl transferase G9a with an endonuclease mutant version of the Cas9 protein for lentiviral delivery. When combined with gene-specific guide RNA, this will result in targeted, local chromatin modification.